Articles by Caroline Humer; Additional reporting by Rod Nickel in Winnipeg, Manitoba; Editing by Bernadette Baum and Lisa Von Ahn
Allergan agrees to $66 billion Actavis deal; Valeant walks
Allergan Inc (AGN.N) on Monday accepted a $66 billion takeover bid from Actavis Plc (ACT.N), closing the door on a hostile offer from activist investor William Ackman and Valeant Pharmaceuticals International Inc (VRX.TO).
Nov 17, 2014 11:59 AM EST
Most Popular
Newsletters
Stay ahead in finance. Subscribe for expert insights, market updates, and investment strategies. Join our newsletter to secure your financial future.
Must Read
